2017年度

Murakami R, Nakayama H, Semba A, Hiraki A, Nagata M, Kawahara K, Shiraishi S, Hirai T, Uozumi H, Yamashita Y.
Prognostic impact of the level of nodal involvement: A retrospective analysis of patients with advanced oral squamous cell carcinoma.
Br J Oral Maxillofac Surg. 55(1):50-5, 2017

Takahashi N, Wei F, Watanabe S, Hirayama M, Ohuchi Y, Fujimura A, Kaitsuka T, Sawa T, Nakayama H, Akaike T, Tomizawa K.
Reactive sulfur species regulate tRNA methylthiolation and contribute to insulin secretion.
Nucleic Acids Res. 45(1):435-45, 2017

Sakata J, Yoshida R, Matsuoka Y, Nagata M, Hirosue A, Kawahara K, Nakamura T, Nakamoto M, Hirayama M, Takahashi N, Nakashima H, Arita H, Ogi, H, Hiraki A, Shinohara M, Nakayama H.
Predictive value of the combination of SMAD4 expression and lymphocyte infiltration in malignant transformation of oral leukoplakia.
Cancer Med. 6(4) :730-8, 2017

Masafumi Nakamoto, Ko Ishihara, Takehisa Watanabe, Akiyuki Hirosue, Shinjiro Hino, Masanori Shinohara, Hideki Nakayama, and Mitsuoshi Nakao
The Glucocorticoid Receptor Regulates the ANGPTL4 Gene in a CTCF-Mediated Chromatin Context in Human Hepatic Cells.
PLOS ONE. 12(1): e0169225, 2017

Tsukamoto H, Fujieda K, Hirayama M, Ikeda T, Yuno A, Matsumura K, Fukuma D, Nakayama H, Senju S, Nishimura Y.
Soluble IL-6R expressed by myeloid cells Th1 differentiation and drives tumor progression.
Cancer Res. 7(9):2279-91, 2017

Tsukamoto H, Fujieda K, Hirayama M, Yuno A, Ikeda T, Matsumura K, Fukuma D, Araki K, Mizuta Nakayama H, Senju S, Nishimura Y
Myeloid cell-derived soluble IL-6 receptor diminishes the differentiation of tumor-specific Th1 cells to exacerbate tumor progression
Cancer Research. 77(9):2279-2291, 2017

Murakami R, Semba A, Kawahara K, Matsuyama K, Hiraki A, Nagata M, Toya R, Yamashita Y, Oya N, Nakayama H.
Concurrent chemoradiotherapy with S-1 in patients with stage III-IV oral squamous cell carcinoma: A retrospective analysis of nodal classification based on the neck node level.
Mol Clin Oncol. 7(1):140-4, 2017

Arita H, Nagata M, Yoshida R, Matsuoka Y, Hirosue A, Kawahara K, Sakata J, Nakashima H, Kojima T, Toya R, Murakami R, Hiraki A, Shinohara M, Nakayama H.
FBWX7 expression affects the response to chemoradiotherapy and overall survival among patients with oral squamous cell carcinoma: a retrospective study
Tumor Biol. 39(10):1010428317731771, 2017

Tsuruta, M., Ueda, S., Yew, P.Y., Fukuda, I., Yoshimura, S., Kishi, H., Hamana, H., Yatsuda, J., Irie, A., Senjyu, S., Yuba, E., Kamba, T., Eto, M., Nakayama, H., and Nishimura.Y*
Bladder cancer-associated cancer-testis antigen-derived long peptides encompassing both CTL and promiscuous HLA class II-restricted Th cell epitopes induced CD4+ T cells expressing converged T-cell receptor genes in vitro. OncoImmunology  published online on Jan. 5, 2018

Sakata J, Yamana K, Yoshida R, Matsuoka Y, Kawahara K, Arita H, Nakashima H, Nagata M, Hirosue A, Kawaguchi S, Gohara S, Nagao Y, Hiraki A, Shinohara M, Toya R, Murakami R, Nakayama H.
Tumor budding as a novel predictor of occult metastasis in cT2N0 tongue squamous cell carcinoma.
Hum Pathol. published online on Jan. 4, 2018

Shinriki S, Jono H, Maeshiro M, Nakamura T, Guo J, Li JD, Ueda M, Yoshida R, Shinohara M, Nakayama H, Matsui H, Ando Y.
Loss of CYLD promotes cell invasion via ALK5 stabilization in oral squamous cell carcinoma.
J Pathol. 244(3):367-79, 2018; published online on Feb. 1, 2018